Skip to content

Effect of exoskeleton-assisted walking on walking in spinal cord injury

Effect of exoskeleton-assisted walking on walking parameters and skeletonal system in spinal cord injury

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000033187
Enrollment
Unknown
Registered
2020-05-23
Start date
2020-05-30
Completion date
Unknown
Last updated
2020-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal cord injury

Interventions

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. aged 18 to 65 years old patients; 2. Patients diagnosed as traumatic or non-traumatic spinal cord injury; 3. The injured ganglion segment was t4-l1; 4. Damage grade: ais-a or B or C; 5. Patients with height of 155-185cm; 6. Before admission, the patients who received corresponding clinical treatment or internal fixation and whose course of disease was more than 4 weeks were confirmed to be stable by X-ray; 7. Subjects or their legal representatives can understand the purpose of the study, show sufficient compliance with the study plan, and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with improved Ashworth grade >=2 of lower extremity muscle tension: 2. Patients with systolic blood pressure > 140 mmHg or diastolic blood pressure > 90 mmHg after drug control; 3. Patients with uncontrollable postural hypotension; 4. Patients with neuromuscular or osteoarticular diseases affecting joint movement (including unstable fracture, loss of joint stability, joint and tendon contracture); 5. Patients with severe osteoporosis; 6. Patients with other diseases that limit their ability to move, such as new deep vein thrombosis of the lower extremities, severe infectious diseases of the bladder or other parts, unstable coronary heart disease or myocardial infarction; 7. Patients with mental illness, hearing impairment and understanding impairment; 8. Patients with weight > 100 kg; 9. Pregnant women, lactating women or women of childbearing age who plan to have a pregnancy during the trial; 10. Other situations that the researcher judges are not suitable for inclusion.

Design outcomes

Primary

MeasureTime frame
Bone mineral density;

Secondary

MeasureTime frame
Knee US;10MWT;

Countries

China

Contacts

Public ContactHongchen He

West China Rehabilitation Medical Center, Chengdu, Sichuan Province

hxkfhhc@126.com+86 18980602262

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026